Local News Seagen Stock Rises as Pfizer Reportedly in Talks to Acquire Seattle-Area Biotech Giant GeekWire | March 3, 2023 Biopharma giant Pfizer is eyeing an acquisition of Seagen, the biggest biotech company in the Seattle…sciencecityMarch 3, 2023 Read More
Local News BBI Faculty Conversations: Dr. Maitreya Dunham Brotman Baty Institute | March 3, 2023 My interest in science started young because I grew up in the woods and I…sciencecityMarch 3, 2023 Read More
Local News A Mysterious Brain Region: The Claustrum Allen Institute | March 2, 2023 Francis Crick was hallucinating about the claustrum. The 88-year-old biologist, best known for his role…sciencecityMarch 2, 2023 Read More
Local News Seven BioE Teams to Compete in the 2023 Health Innovation Challenge Finals UW Department of Bioengineering | March 2, 2023 Congratulations to the seven UW Bioengineering-related teams competing in the 2023 Holloman Health Innovation Challenge (HIC) March…sciencecityMarch 2, 2023 Read More
Local News NIH Funds Collaborative Effort to Pinpoint the Origins of Duchenne Muscular Dystrophy UW | February 23, 2021 Duchenne muscular dystrophy (DMD) is a severe degenerative muscle disease caused by mutations in the…kchenFebruary 23, 2021 Read More
Local News Astellas and Seagen Announce Submission of Two Supplemental Biologics License Applications to the FDA for PADCEV® in Locally Advanced or Metastatic Urothelial Cancer BioSpace | February 22, 2021 Astellas Pharma US (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Seagen, Inc. (Nasdaq:SGEN) today…kchenFebruary 22, 2021 Read More
Local News Notch Therapeutics Raises $85M for Cancer Treatments and Plans to Open Seattle Location GeekWire | February 22, 2021 New funding: Notch Therapeutics has raised a $85 million Series A round, bringing its total funding to…kchenFebruary 22, 2021 Read More
Local News Seagen and Astellas Announce Phase 3 Trial Results Demonstrating Survival Advantage of PADCEV® in Patients with Previously Treated Advanced Urothelial Cancer Seagen | February 18, 2021 Seagen Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D.,…emcguinnFebruary 18, 2021 Read More
Local News BBI Grant Leads to NIH Funding Enabling Dr. Taran Gujral to Study FLC and Other Rare Cancers Brotman Baty Institute | November 1, 2023 Fibrolamellar carcinoma (FLC) is a liver cancer that typically affects teenagers and adults under age…sciencecityNovember 1, 2023 Read More
Local News ‘AI-Triaged’ 3D Pathology Improves Cancer Detection UW Medicine | November 1, 2023 An interdisciplinary research team including Wynn Burke, research consultant, and Dr. William Grady, professor (Gastroenterology)…sciencecityNovember 1, 2023 Read More
Awards Benaroya Research Institute’s Dr. Carla Greenbaum Receives Puget Sound Business Journal Lifetime Achievement Award Benaroya Research Institute | October 31, 2023 This week, the Puget Sound Business Journal tapped Carla Greenbaum, MD for this year’s Lifetime…sciencecityOctober 31, 2023 Read More